BioMed Research International / 2018 / Article / Fig 4

Research Article

LincRNA-p21 Inhibits Cell Viability and Promotes Cell Apoptosis in Parkinson’s Disease through Activating -Synuclein Expression

Figure 4

LincRNA-p21 and miR-1277-5p regulated -synuclein expression and effects of coexpressing lincRNA-p21 and miR-1277-5p mimics on cell viability and apoptosis were detected in SH-SY5Y cells treated with MPP+. (a, b) The luciferase activity was detected after cotransfection of lincRNA-p21 and miR-1277-5p mimics/inhibitor in α-synuclein group. (c, d) The expression of α-synuclein was measured after cotransfection of lincRNA-p21 and miR-1277-5p mimics/inhibitor. (e) Cell viability was measured after cotransfection of lincRNA-p21 and miR-1277-5p mimics in SH-SY5Y cells. (f) Cell apoptosis was observed after cotransfection of lincRNA-p21 and miR-1277-5p mimics in SH-SY5Y cells. All data are shown as the mean ± SD (P < 0.05, P < 0.01, P < 0.001); bar, SD.
(a)
(b)
(c)
(d)
(e)
(f)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.